PR Newswire
LEIDEN, The Netherlands , Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's management will participate in the following investor conferences in the U.S. in the month of September:
- 2023 Wells Fargo Healthcare Conference, Boston , September 6-8
Sijmen de Vries, Chief Executive Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Thursday, September 7 at 16:30 ET / 22:30 CET . A live webcast and replay of the fireside chat will be available in the "Upcoming Events" and "News" sections of Pharming's website. - H.C. Wainwright 25 th Annual Global Investment Conference, New York , September 11-13
Sijmen de Vries, Chief Executive Officer, will present on Wednesday, September 13 at 08:30 ET / 14:30 CET . A live webcast and replay of the presentation will be available in the "Upcoming Events" and "News" sections of Pharming's website. - 2023 Cantor Global Healthcare Conference, New York , September 26-28
Michael Levitan, VP Investor Relations and Corporate Communications, will present on Thursday, September 28 at 10:20 ET / 16:20 CET .
For more information about these conferences, or to schedule a one-to-one meeting with Pharming's management team, please contact Pharming's Investor Relations team at investor@pharming.com or your Wells Fargo, H.C. Wainwright or Cantor representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands , and has employees around the globe who serve patients in over 30 markets in North America , Europe , the Middle East , Africa , and Asia-Pacific .
For more information, visit www.pharming.com and find us on LinkedIn .
For further public information, contact:
Pharming Group, Leiden, The Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
Heather Robertson , Investor Relations & Corporate Communications Manager
E: investor@pharming.com
FTI Consulting, London, UK
Victoria Foster Mitchell / Alex Shaw / Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
SOURCE Pharming Group N.V.